A Dutch firm’s AI-powered machines that draw blood with more accuracy than humans without the patient seeing the needle to be ...

The patient rests their palm on the device ... and releases pressure to encourage and then staunch blood flow once a sufficient sample size — up to 400 microlitres — has been collected.

Inspira Technologies' innovative blood sensor is gaining attention. According to a recent announcement, results from the device's clinical evaluation are due imminently ...

Mixing ball helps you obtain a homogeneous sample SafeTIPCAP minimizes the risk of blood contact Barcode helps you get a correct match between your patient and blood sample Integrated needle ...

The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago.

from patient whole blood samples. The drug – codenamed EXS21546 – started clinical testing earlier this year and according to Exscientia is the first AI-derived immuno-oncology candidate to be ...

Unlike with a traditional blood draw, the patient does not see the needle go into the arm nor the tubes of blood. The process takes about two minutes and has a 95% success rate on the first attempt.

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

The test, run on Abbott's portable i-STAT Alinity instrument, uses whole blood to help evaluate patients 18 years and above ...